Substratification of stage T1C prostate cancer based on the probability of biochemical recurrence
- 1 December 2002
- Vol. 60 (6) , 1034-1039
- https://doi.org/10.1016/s0090-4295(02)01997-0
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- PERCENT PROSTATE NEEDLE BIOPSY TISSUE WITH CANCER IS MORE PREDICTIVE OF BIOCHEMICAL FAILURE OR ADVERSE PATHOLOGY AFTER RADICAL PROSTATECTOMY THAN PROSTATE SPECIFIC ANTIGEN OR GLEASON SCOREJournal of Urology, 2002
- PREDICTING PROSTATE SPECIFIC ANTIGEN OUTCOME PREOPERATIVELY IN THE PROSTATE SPECIFIC ANTIGEN ERAJournal of Urology, 2001
- ERA SPECIFIC BIOCHEMICAL RECURRENCE-FREE SURVIVAL FOLLOWING RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCERJournal of Urology, 2001
- Cancer Statistics, 2001CA: A Cancer Journal for Clinicians, 2001
- VALIDATION OF PARTIN TABLES FOR PREDICTING PATHOLOGICAL STAGE OF CLINICALLY LOCALIZED PROSTATE CANCERJournal of Urology, 2000
- OUTCOME BASED STAGING FOR CLINICALLY LOCALIZED ADENOCARCINOMA OF THE PROSTATEJournal of Urology, 1997
- Hazard rates for progression after radical prostatectomy for clinically localized prostate cancerUrology, 1997
- Analysis of Risk Factors for Progression in Patients with Pathologically Confined Prostate Cancers After Radical Retropubic ProstatectomyJournal of Urology, 1996
- Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomyUrology, 1995
- Radical prostatectomy for adenocarcinoma of the prostate: The influence of preoperative and pathologic findings on biochemical disease-free outcomeUrology, 1994